• Something wrong with this record ?

Low molecular weight hyaluronan mediated CD44 dependent induction of IL-6 and chemokines in human dermal fibroblasts potentiates innate immune response

L. Vistejnova, B. Safrankova, K. Nesporova, R. Slavkovsky, M. Hermannova, P. Hosek, V. Velebny, L. Kubala,

. 2014 ; 70 (2) : 97-103. [pub] 20140810

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc16010752

Complex regulation of the wound healing process involves multiple interactions among stromal tissue cells, inflammatory cells, and the extracellular matrix. Low molecular weight hyaluronan (LMW HA) derived from the degradation of high molecular weight hyaluronan (HMW HA) is suggested to activate cells involved in wound healing through interaction with HA receptors. In particular, receptor CD44 is suggested to mediate cell response to HA of different MW, being the main cell surface HA receptor in stromal tissue and immune cells. However, the response of dermal fibroblasts, the key players in granulation tissue formation within the wound healing process, to LMW HA and their importance for the activation of immune cells is unclear. In this study we show that LMW HA (4.3kDa) induced pro-inflammatory cytokine IL-6 and chemokines IL-8, CXCL1, CXCL2, CXCL6 and CCL8 gene expression in normal human dermal fibroblasts (NHDF) that was further confirmed by increased levels of IL-6 and IL-8 in cell culture supernatants. Conversely, NHDF treated by HMW HA revealed a tendency to decrease the gene expression of these cytokine and chemokines when compared to untreated control. The blockage of CD44 expression by siRNA resulted in the attenuation of IL-6 and chemokines expression in LMW HA treated NHDF suggesting the involvement of CD44 in LMW HA mediated NHDF activation. The importance of pro-inflammatory mediators produced by LMW HA triggered NHDF was evaluated by significant activation of blood leukocytes exhibited as increased production of IL-6 and TNF-α. Conclusively, we demonstrated a pro-inflammatory response of dermal fibroblasts to LMW HA that was transferred to leukocytes indicating the significance of LMW HA in the inflammatory process development during the wound healing process.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010752
003      
CZ-PrNML
005      
20160413100425.0
007      
ta
008      
160408s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.cyto.2014.07.006 $2 doi
024    7_
$a 10.1016/j.cyto.2014.07.006 $2 doi
035    __
$a (PubMed)25126764
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vistejnova, Lucie $u Contipro Biotech spol. s.r.o., Dolni Dobrouc, Czech Republic; Institute of Experimental Biology, Department of Physiology and Immunology of Animals, Faculty of Science, Masaryk University, Brno, Czech Republic; Biomedical Center, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
245    10
$a Low molecular weight hyaluronan mediated CD44 dependent induction of IL-6 and chemokines in human dermal fibroblasts potentiates innate immune response / $c L. Vistejnova, B. Safrankova, K. Nesporova, R. Slavkovsky, M. Hermannova, P. Hosek, V. Velebny, L. Kubala,
520    9_
$a Complex regulation of the wound healing process involves multiple interactions among stromal tissue cells, inflammatory cells, and the extracellular matrix. Low molecular weight hyaluronan (LMW HA) derived from the degradation of high molecular weight hyaluronan (HMW HA) is suggested to activate cells involved in wound healing through interaction with HA receptors. In particular, receptor CD44 is suggested to mediate cell response to HA of different MW, being the main cell surface HA receptor in stromal tissue and immune cells. However, the response of dermal fibroblasts, the key players in granulation tissue formation within the wound healing process, to LMW HA and their importance for the activation of immune cells is unclear. In this study we show that LMW HA (4.3kDa) induced pro-inflammatory cytokine IL-6 and chemokines IL-8, CXCL1, CXCL2, CXCL6 and CCL8 gene expression in normal human dermal fibroblasts (NHDF) that was further confirmed by increased levels of IL-6 and IL-8 in cell culture supernatants. Conversely, NHDF treated by HMW HA revealed a tendency to decrease the gene expression of these cytokine and chemokines when compared to untreated control. The blockage of CD44 expression by siRNA resulted in the attenuation of IL-6 and chemokines expression in LMW HA treated NHDF suggesting the involvement of CD44 in LMW HA mediated NHDF activation. The importance of pro-inflammatory mediators produced by LMW HA triggered NHDF was evaluated by significant activation of blood leukocytes exhibited as increased production of IL-6 and TNF-α. Conclusively, we demonstrated a pro-inflammatory response of dermal fibroblasts to LMW HA that was transferred to leukocytes indicating the significance of LMW HA in the inflammatory process development during the wound healing process.
650    _2
$a antigeny CD44 $x metabolismus $7 D018960
650    _2
$a chemokiny $x biosyntéza $x genetika $7 D018925
650    _2
$a škára $x cytologie $7 D020405
650    _2
$a fibroblasty $x účinky léků $x imunologie $7 D005347
650    _2
$a lidé $7 D006801
650    _2
$a kyselina hyaluronová $x farmakologie $7 D006820
650    _2
$a přirozená imunita $x účinky léků $x genetika $7 D007113
650    _2
$a mediátory zánětu $x metabolismus $7 D018836
650    _2
$a interleukin-6 $x biosyntéza $x genetika $x metabolismus $7 D015850
650    _2
$a interleukin-8 $x biosyntéza $7 D016209
650    _2
$a leukocyty $x účinky léků $x metabolismus $7 D007962
650    _2
$a molekulová hmotnost $7 D008970
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    _2
$a malá interferující RNA $x metabolismus $7 D034741
650    _2
$a signální transdukce $x účinky léků $x genetika $7 D015398
650    _2
$a TNF-alfa $x biosyntéza $7 D014409
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Safrankova, Barbora $u Contipro Biotech spol. s.r.o., Dolni Dobrouc, Czech Republic; Institute of Experimental Biology, Department of Physiology and Immunology of Animals, Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Nesporova, Kristina $u Contipro Biotech spol. s.r.o., Dolni Dobrouc, Czech Republic; Institute of Experimental Biology, Department of Physiology and Immunology of Animals, Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Slavkovsky, Rastislav $u Contipro Biotech spol. s.r.o., Dolni Dobrouc, Czech Republic.
700    1_
$a Hermannova, Martina $u Contipro Biotech spol. s.r.o., Dolni Dobrouc, Czech Republic.
700    1_
$a Hosek, Petr $u Biomedical Center, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
700    1_
$a Velebny, Vladimir $u Contipro Biotech spol. s.r.o., Dolni Dobrouc, Czech Republic.
700    1_
$a Kubala, Lukas $u Institute of Biophysics, Academy of Science of the Czech Republic v.v.i., Czech Republic; International Clinical Research Center - Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, Brno, Czech Republic. Electronic address: kubalal@ibp.cz.
773    0_
$w MED00001313 $t Cytokine $x 1096-0023 $g Roč. 70, č. 2 (2014), s. 97-103
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25126764 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160413100508 $b ABA008
999    __
$a ok $b bmc $g 1114181 $s 935120
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 70 $c 2 $d 97-103 $e 20140810 $i 1096-0023 $m Cytokine (Philadelphia, Pa. Print) $n Cytokine $x MED00001313
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Archiving options